| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 11/06/2002 | EP1254266A1 Methods and materials relating to alpha-2-macroglobulin-like polypeptides and polynucleotides |
| 11/06/2002 | EP1254265A1 Methods and materials relating to metallocarboxypeptidase-like polypeptides and polynucleotides |
| 11/06/2002 | EP1254264A1 Human protein tyrosine phosphatase polynucleotides, polypeptides, and antibodies |
| 11/06/2002 | EP1254263A2 Interferon-alpha induced genes |
| 11/06/2002 | EP1254260A1 Methods for diagnosing and treating heart disease |
| 11/06/2002 | EP1254259A1 Antisense modulation of pepck-cytosolic expression |
| 11/06/2002 | EP1254258A1 A method for detection of pathogenic organisms |
| 11/06/2002 | EP1254257A2 METHOD FOR GENERATION OF LONGER cDNA FRAGMENTS FROM SAGE TAGS FOR GENE IDENTIFICATION |
| 11/06/2002 | EP1254256A2 Novel nucleic acids and polypeptides |
| 11/06/2002 | EP1254255A1 Trefoil domain-containing polynucleotides, polypeptides, and antibodies |
| 11/06/2002 | EP1254254A2 Nucleic acid molecules for detecting bacteria and phylogenetic units of bacteria |
| 11/06/2002 | EP1254253A1 Single stranded oligonucleotides, probes, primers and method for detecting spirochetes |
| 11/06/2002 | EP1254248A2 Nucleic acids, proteins, and antibodies |
| 11/06/2002 | EP1254246A1 Methods and materials relating to transforming growth factor alpha-like polypeptides and polynucleotides |
| 11/06/2002 | EP1254245A1 Regulated expression of plac in staphylococcus aureus |
| 11/06/2002 | EP1254244A2 Manufacture of five-carbon sugars and sugar alcohols |
| 11/06/2002 | EP1254243A1 Transgenic cells expressing glucosyltransferase nucleic acids |
| 11/06/2002 | EP1254242A1 17 human secreted proteins |
| 11/06/2002 | EP1254241A2 Phosphatases |
| 11/06/2002 | EP1254240A2 Proteins producing an altered immunogenic response and methods of making and using the same |
| 11/06/2002 | EP1254239A2 Mammalian secreted group iii phospholipase a2 |
| 11/06/2002 | EP1254238A2 Novel elongase gene and method for producing multiple-unsaturated fatty acids |
| 11/06/2002 | EP1254236A2 Drug metabolizing enzymes |
| 11/06/2002 | EP1254235A2 Drug metabolizing enzymes |
| 11/06/2002 | EP1254234A1 Haemophilus influenza outer membrane protein and use thereof in vaccination |
| 11/06/2002 | EP1254233A1 Use of a leptospire protein for preventing and/or diagnosing and/or treating animal and/or human leptospirosis |
| 11/06/2002 | EP1254232A2 Corynebacterium glutamicum genes encoding proteins involved in homeostasis and adaptation |
| 11/06/2002 | EP1254231A1 Genes encoding abc1 paralogs and the polypeptides derived therefrom |
| 11/06/2002 | EP1254230A2 1983, 52881, 2398, 45449, 50289, and 52872, g protein-coupled receptors and uses therefor |
| 11/06/2002 | EP1254229A1 Vector constructs for gene-therapy mediated radionuclide therapy of undifferentiated and medullary thyroid carcinomas and non-thyroidal tumours and the metastases thereof |
| 11/06/2002 | EP1254228A1 Nucleic acids, proteins, and antibodies |
| 11/06/2002 | EP1254226A2 Inhibitors of apoptosis |
| 11/06/2002 | EP1254225A2 Novel family of proteins, called atip, nucleic sequences coding for same and uses thereof |
| 11/06/2002 | EP1254224A2 Interferon-alpha induced genes |
| 11/06/2002 | EP1254223A1 Cysteinyl leukotriene receptor 2 (cyslt2) |
| 11/06/2002 | EP1254222A1 Human gaba receptor proteins and polynucleotides encoding the same |
| 11/06/2002 | EP1254220A1 Human g-protein coupled 7 transmembrane receptor and polynucleotides encoding the same |
| 11/06/2002 | EP1254219A2 Nucleic acids, proteins, and antibodies |
| 11/06/2002 | EP1254218A2 Nucleic acids, proteins, and antibodies |
| 11/06/2002 | EP1254217A2 Nucleic acids, proteins, and antibodies |
| 11/06/2002 | EP1254216A2 Improved galactosylation of recombinant glycoproteins |
| 11/06/2002 | EP1254214A2 Human protein kinases and protein kinase-like enzymes |
| 11/06/2002 | EP1254213A2 Recombinant attenuation of prrsv |
| 11/06/2002 | EP1254212A2 Methods of preparing and using a viral vector library |
| 11/06/2002 | EP1254211A1 Cell production |
| 11/06/2002 | EP1254210A2 Method for cloning animals with targetted genetic alterations by transfer of long-term cultured male or female somatic cell nuclei, comprising artificially-induced genetic alterations, to enucleated recipient cells |
| 11/06/2002 | EP1254180A1 Canine allergy therapeutic recombinant chimeric anti-ige monoclonal antibody |
| 11/06/2002 | EP1254179A1 An in vivo screen using chemical inducers of dimerization |
| 11/06/2002 | EP1254177A1 RUMINANT MHC CLASS I-LIKE Fc RECEPTORS |
| 11/06/2002 | EP1254176A2 Trade molecules and uses related thereto |
| 11/06/2002 | EP1254175A1 Human cystine knot polypeptide |
| 11/06/2002 | EP1254174A2 Human cyr61 |
| 11/06/2002 | EP1254173A1 Nucleic acids, proteins, and antibodies |
| 11/06/2002 | EP1254172A1 Nucleic acids, proteins, and antibodies |
| 11/06/2002 | EP1254170A2 Nucleic acids, proteins, and antibodies |
| 11/06/2002 | EP1254169A2 Methods and compositions relating to modulation of hepatocyte growth, plasma cell differentiation or t cell subset activity by modulation of xbp-1 activity |
| 11/06/2002 | EP1254168A2 Cytokine inhibittory molecules from tick salivary glands |
| 11/06/2002 | EP1254167A2 Preparation of deallergenized patatin proteins and patatin permutein proteins |
| 11/06/2002 | EP1254165A2 Nucleic acids, proteins, and antibodies |
| 11/06/2002 | EP1254156A1 Transgenic plant-based vaccines |
| 11/06/2002 | EP1254154A2 Nucleic acids, proteins, and antibodies |
| 11/06/2002 | EP1254153A2 Nucleic acids, proteins, and antibodies |
| 11/06/2002 | EP1254152A2 Nucleic acids, proteins, and antibodies |
| 11/06/2002 | EP1254151A1 Nucleic acids, proteins, and antibodies |
| 11/06/2002 | EP1254150A2 Nucleic acids, proteins, and antibodies |
| 11/06/2002 | EP1254149A1 Methods and compositions for bioremediation |
| 11/06/2002 | EP1254147A2 Nucleic acids, proteins, and antibodies |
| 11/06/2002 | EP1253948A2 Gene therapy for treating ocular-related disorders |
| 11/06/2002 | EP1253942A1 Cd40-binding apc-activating molecules |
| 11/06/2002 | EP1253930A2 Method and compositions for treating hepatocellular cancer |
| 11/06/2002 | EP1253928A2 Novel haptotactic peptides |
| 11/06/2002 | EP1253823A1 Controlling offspring's sex ratio by targeting transgenes onto the sex chromosomes |
| 11/06/2002 | EP1145448B1 Radio communications unit |
| 11/06/2002 | EP1135518A4 Transgenic animals as urinary bioreactors for the production of protein in the urine, recombinant dna construct for kidney-specific expression, and method of using same |
| 11/06/2002 | EP1045642B1 Animal nutrition compositions |
| 11/06/2002 | EP1007718A4 Polymerase enhancing factor (pef) extracts, pef protein complexes, isolated pef protein, and methods for purifying and identifying |
| 11/06/2002 | EP0953039A4 Animal models of human prostate cancer progression |
| 11/06/2002 | EP0909277A3 Humanized antibodies that bind to the same antigen as bound by antibody nr-lu-13, and their use in pretargeting methods |
| 11/06/2002 | EP0907889A4 Light-controlled electrokinetic assembly of particles near surfaces |
| 11/06/2002 | EP0873427B8 Process for detecting and quantifying nucleic acid molecules |
| 11/06/2002 | EP0824598B1 METHOD FOR THE SPECIFIC COUPLING OF THE CAP OF THE EXTREMITY 5' OF A FRAGMENT mRNA AND PREPARATION OF mRNA AND COMPLETE cDNA |
| 11/06/2002 | EP0824542A4 End-complementary polymerase reaction |
| 11/06/2002 | EP0773959B1 Adrenergic receptor |
| 11/06/2002 | EP0757720B1 Trimerising polypeptides, their manufacture and use |
| 11/06/2002 | EP0748382B1 Non-nucleotide containing enzymatic nucleic acid |
| 11/06/2002 | EP0689550B1 Antimicrobial peptides from bovine neutrophils |
| 11/06/2002 | CN1378648A Method for determining leptin |
| 11/06/2002 | CN1378602A Plants with modified poly unsaturated fatty acids |
| 11/06/2002 | CN1378601A Plants having altered amino acid contents and method for production thereof |
| 11/06/2002 | CN1378600A Nucleic acid molecules derived from plants whihc code for enzymes which are involved in synthesis of starch |
| 11/06/2002 | CN1378599A Generation and genetic transformation of Acacia mangium |
| 11/06/2002 | CN1378598A Evolution and use of enzymes for combinathorial and medicinal chemistry |
| 11/06/2002 | CN1378597A Immunogenic polypeptides derived from morazella catarrhalis and uses thereof |
| 11/06/2002 | CN1378596A BASB 111 polypeptide and polynucleotide from moraxella cathraahalis |
| 11/06/2002 | CN1378595A Human cytokine as ligand of zalpha receptor and use thereof |
| 11/06/2002 | CN1378594A T-cell receptor gamma alternate reading frame protein (TARP) and uses thereof |
| 11/06/2002 | CN1378593A Method and compostions for construction and use of fusion libraries |
| 11/06/2002 | CN1378592A Method for RNA ase-and organic solvent-free plasmid DNA purification using tangential flow filtration |
| 11/06/2002 | CN1378591A Bacterial protection |
| 11/06/2002 | CN1378560A Compounds for treatment of infectious and immune system disorders and method for their use |